View Regeneron Pharmaceuticals, Inc. REGN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Regeneron Pharmaceuticals reported strong ... and marketed numerous fully human monoclonal antibodies utilizing their VelociSuite platform technology. This platform allows for the rapid generation ...

Trap and Regeneron’s antibody drug platform VelociSuite gave birth to multiple popular drugs, including Sanofi’s top-selling product, IL-4/13 inhibitor Dupixent. In 2022, Regeneron recorded ...

The collaboration integrates Regeneron’s industry-leading VelociSuite® technologies for the discovery and characterization of fully human antibodies and T cell receptors (TCRs) with Sonoma Bio ...

Regeneron Pharmaceuticals ... accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized ...

Regeneron Pharmaceuticals ... accelerates the traditional drug development process through its proprietary VelociSuite t ...